Key result
In a patient with cardiogenic shock from takotsubo cardiomyopathy and LVOT obstruction, treatment with phenylephrine and beta-blockers led to clinical recovery and resolution of obstruction.
Why the study?
A subset of patients with takotsubo cardiomyopathy develop dynamic LVOT obstruction leading to cardiogenic shock, where traditional inotropic and afterload-reducing therapies can be detrimental.
Case Report (n=1)
In cardiogenic shock due to takotsubo cardiomyopathy with LVOT obstruction, traditional therapies like inotropes and IABP can be detrimental, whereas vasopressors (phenylephrine) and beta-blockers may improve hemodynamics.
Answers are grounded in this paper and cite their sources.
May favor phenylephrine and beta-blockers in takotsubo shock with LVOT obstruction; hypothesis-generating pending controlled trials.
BACKGROUND: A subset of patients with takotsubo cardiomyopathy will develop significant dynamic left ventricular outflow tract (LVOT) obstruction leading to cardiogenic shock. However, traditional therapies for cardiogenic shock that focus on increased inotropy and afterload reduction can be detrimental in this situation. CASE SUMMARY: We describe a 71-year-old woman who presented to the emergency department with typical, substernal chest pain found to be hypotensive with ST-elevations in the lateral leads. Coronary angiography showed no significant coronary artery disease, but a left ventriculogram demonstrated takotsubo cardiomyopathy. Right heart catheterization revealed cardiogenic shock and elevated filling pressures. Haemodynamics and symptoms worsened with the initiation of dopamine and placement of intra-aortic balloon pump but improved with the initiation of phenylephrine. Follow-up echocardiogram demonstrated dynamic LVOT obstruction with concomitant severe mitral regurgitation (MR). The patient recovered in the intensive care unit for 5 days after successful weaning of phenylephrine and initiation of low-dose beta-blocker. Repeat echocardiogram 3 weeks later showed complete resolution of apical akinesis, LVOT obstruction, and MR. DISCUSSION: Elucidating whether dynamic LVOT obstruction is contributing to cardiogenic shock physiology is paramount since the management radically differs depending on the presence or absence of obstruction. Corrective therapy focuses on reducing the LVOT gradient and includes fluid administration to improve preload, beta-blocker therapy to increase diastolic filling time, and vasopressors to raise afterload.
No takes yet. Share an insight, caveat, or question.
Bui et al. (2021) conducted a case report in Takotsubo cardiomyopathy with left ventricular outflow tract obstruction and cardiogenic shock (n=1). Phenylephrine and beta-blocker therapy was evaluated on Clinical recovery and resolution of LVOT obstruction. In a patient with cardiogenic shock from takotsubo cardiomyopathy and LVOT obstruction, treatment with phenylephrine and beta-blockers led to clinical recovery and resolution of obstruction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: